|
|
||||||||

* Howard Hughes Medical Institute and Departments of Medicine and Microbiology and Immunology, University of California, San Francisco, CA 94143; and
Bioscience and Biotechnology, Sejong University, Seoul, Korea
IL-12p40 is induced in macrophages and dendritic cells (DC) after activation by microbial TLR ligands and cytokines and constitutes a component of IL-12 and IL-23. In an effort to understand the location and kinetics of these cytokines during the course of an immune response, we generated knockin (gene-targeted) mice that express the p40 gene linked via a viral internal ribosome entry site element with fluorescent reporters, eYFP or eGFP. Macrophages and DC from these mice faithfully reported biallelic p40 induction using the fluorescent marker. s.c. inoculation with Listeria monocytogenes or LPS led to a rapid, but transient, accumulation of p40-expressing DC in draining lymph nodes, which could be blocked by the addition of pertussis toxin. In situ analysis also revealed the accumulation of IL-12p40 protein around high endothelial venules located in close proximity to p40-expressing DC. Consistent with the in vivo findings, in vitro-activated DC that expressed p40 migrated to draining lymph nodes and promoted Th1 differentiation more efficiently than DC that did not express p40. Accordingly, these mice provide a valuable tool for tracking critical functions of DC in vivo and should bestow a useful reagent for exploring the effector biology of these cells in models of infectious disease, cancer immunity, and vaccine development.
This article has been cited by other articles:
![]() |
S. Kim, J. Y. Yang, K. Lee, K. H. Oh, M. Gi, J. M. Kim, D. J. Paik, S. Hong, and J. Youn Bacillus subtilis-specific poly-{gamma}-glutamic acid regulates development pathways of naive CD4+ T cells through antigen-presenting cell-dependent and -independent mechanisms Int. Immunol., June 26, 2009; (2009) dxp065v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Rothfuchs, J. G. Egen, C. G. Feng, L. R. V. Antonelli, A. Bafica, N. Winter, R. M. Locksley, and A. Sher In Situ IL-12/23p40 Production during Mycobacterial Infection Is Sustained by CD11bhigh Dendritic Cells Localized in Tissue Sites Distinct from Those Harboring Bacilli J. Immunol., June 1, 2009; 182(11): 6915 - 6925. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Qiu, Y. Miyake, H. Kaise, H. Kitamura, O. Ohara, and M. Tanaka Novel Subset of CD8{alpha}+ Dendritic Cells Localized in the Marginal Zone Is Responsible for Tolerance to Cell-Associated Antigens J. Immunol., April 1, 2009; 182(7): 4127 - 4136. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Melli, R. S. Friedman, A. E. Martin, E. B. Finger, G. Miao, G. L. Szot, M. F. Krummel, and Q. Tang Amplification of Autoimmune Response through Induction of Dendritic Cell Maturation in Inflamed Tissues J. Immunol., March 1, 2009; 182(5): 2590 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Lee, M. Zamora, M. M. Linehan, N. Iijima, D. Gonzalez, A. Haberman, and A. Iwasaki Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection J. Exp. Med., February 16, 2009; 206(2): 359 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Louvet, G. L. Szot, J. Lang, M. R. Lee, N. Martinier, G. Bollag, S. Zhu, A. Weiss, and J. A. Bluestone Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice PNAS, December 2, 2008; 105(48): 18895 - 18900. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Robinson, S. A. Khader, R. M. Locksley, E. Lien, S. T. Smiley, and A. M. Cooper Yersinia pestis Evades TLR4-dependent Induction of IL-12(p40)2 by Dendritic Cells and Subsequent Cell Migration J. Immunol., October 15, 2008; 181(8): 5560 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bouabe, R. Fassler, and J. Heesemann Improvement of reporter activity by IRES-mediated polycistronic reporter system Nucleic Acids Res., March 1, 2008; 36(5): e28 - e28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Reiner, F. Sallusto, and A. Lanzavecchia Division of Labor with a Workforce of One: Challenges in Specifying Effector and Memory T Cell Fate Science, August 3, 2007; 317(5838): 622 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Elliott, R. A. Scolyer, S. Suciu, S. Lebecque, D. Rimoldi, O. Gugerli, E. Musat, R. N. Sharma, D. Lienard, U. Keilholz, et al. Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma Clin. Cancer Res., July 1, 2007; 13(13): 3825 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Toubi, A Kessel, G Slobodin, N Boulman, E Pavlotzky, D Zisman, M Rozenbaum, and I Rosner Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis Ann Rheum Dis, June 1, 2007; 66(6): 818 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Shamshiev, F. Ampenberger, B. Ernst, L. Rohrer, B. J. Marsland, and M. Kopf Dyslipidemia inhibits Toll-like receptor-induced activation of CD8{alpha}-negative dendritic cells and protective Th1 type immunity J. Exp. Med., February 19, 2007; 204(2): 441 - 452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |